The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice.
Lynden RobertsKathleen TymmsJulien de JagerGeoffrey Owen LittlejohnHedley GriffithsDave NichollsPaul BirdJennifer YoungJulie HillJane ZochlingPublished in: International journal of rheumatology (2017)
In this large Australian cohort of unselected community RA patients, the choices of cDMARDs/bDMARDs are aligned with current international guidelines.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- primary care
- prognostic factors
- mental health
- rheumatoid arthritis patients
- patient reported outcomes
- systemic lupus erythematosus
- ankylosing spondylitis
- quality improvement
- patient reported
- interstitial lung disease